Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
14.47
+0.34 (2.41%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Embecta Revenue
Embecta had revenue of $272.50M in the quarter ending June 30, 2024, a decrease of -4.75%. This brings the company's revenue in the last twelve months to $1.12B, up 0.48% year-over-year. In the fiscal year ending September 30, 2023, Embecta had annual revenue of $1.12B, down -0.77%.
Revenue (ttm)
$1.12B
Revenue Growth
+0.48%
P/S Ratio
0.74
Revenue / Employee
$508,591
Employees
2,200
Market Cap
834.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2023 | 1.12B | -8.70M | -0.77% |
| Sep 30, 2022 | 1.13B | -35.80M | -3.07% |
| Sep 30, 2021 | 1.17B | 79.80M | 7.35% |
| Sep 30, 2020 | 1.09B | -23.50M | -2.12% |
| Sep 30, 2019 | 1.11B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healthcare Services Group | 1.70B |
| Cronos Group | 101.78M |
| AbCellera Biologics | 33.05M |
| Silence Therapeutics | 22.62M |
| Dianthus Therapeutics | 4.12M |
| Perspective Therapeutics | 1.46M |
EMBC News
- 2 months ago - embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes - GlobeNewsWire
- 2 months ago - embecta to Participate in Investor Events - GlobeNewsWire
- 2 months ago - Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results - GlobeNewsWire
- 2 months ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 3 months ago - Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company - PRNewsWire
- 3 months ago - embecta to Report Fiscal Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir - GlobeNewsWire